๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial

โœ Scribed by D. V. Jeste; Mark Klausner; Martin Brecher; Christopher Clyde; Robert Jones; ARCS Study Group


Publisher
Springer
Year
1997
Tongue
English
Weight
259 KB
Volume
131
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effectiveness of antipsychotic polypharm
โœ Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Shinichiro Nakajima; Kensuk ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB ๐Ÿ‘ 2 views

## Abstract ## Objective To evaluate the effectiveness of antipsychotic polypharmacy in a methodologically sound manner. ## Methods In this openโ€label study, 17 patients with treatmentโ€refractory schizophrenia, who failed to respond to a sequential monotherapy with olanzapine, quetiapine and ris

Safety and efficacy of long-acting injec
โœ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB ๐Ÿ‘ 2 views

## Abstract The study aimed to evaluate the efficacy of longโ€acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twentyโ€five patients enrolled in this 6โ€month open labelled study. They were switched from their current antipsychotic to LAR without a prior or